GGrantIndex
← Search

DEVELOPMENT AND PRECLINICAL VALIDATION OF AN IMPROVED TISSUE ENGINEERED VASCULAR GRAFT FOR USE IN CONGENITAL HEART SURGERY

$4,049,040FY2018Defense Health AgencyDOD

Research Institute At Nationwide Children'S Hospital

Investigators

View source on USAspending →